March 2016 Highlights

Om avsnittet

This month, Deputy Editor Susan K. Schultz, M.D., discusses depression following stroke; cerebral abnormalities in patients with first-episode schizophrenia; risks of poorly monitored ketamine use for depression; long-term outcomes of light therapy versus CBT for seasonal affective disorder; the reproductive safety of second-generation antipsychotics; and the effects of antipsychotic review and nonpharmacological interventions on antipsychotic use, symptoms, and mortality in nursing home residents. Articles may be viewed online at ajp.psychiatryonline.org.

Om avsnittet

Fler avsnitt

October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions

September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial

81: Psychiatric Risk Associated With Large Language Model Chatbots: An Emerging Concern

August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure

July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care

June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Special Episode: The Future of DSM

May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample

April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts

March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial